Cost-Minimization Analysis of the Women's Cancer Risk Identification-Quantitative Polymerase Chain Reaction Test for Endometrial Cancer Epigenetic Biomarker Compared With Transvaginal Ultrasound for Triaging Abnormal Uterine Bleeding.

Saved in:
Bibliographic Details
Title: Cost-Minimization Analysis of the Women's Cancer Risk Identification-Quantitative Polymerase Chain Reaction Test for Endometrial Cancer Epigenetic Biomarker Compared With Transvaginal Ultrasound for Triaging Abnormal Uterine Bleeding.
Authors: Snowsill TM; Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, England, UK. Electronic address: t.m.snowsill@exeter.ac.uk., Sleigh S; European Translational Oncology Prevention and Screening Institute, University of Innsbruck, Innsbruck, Austria; Sola Diagnostics GmbH, Innsbruck, Austria., Barrett J; European Translational Oncology Prevention and Screening Institute, University of Innsbruck, Innsbruck, Austria., Widschwendter M; European Translational Oncology Prevention and Screening Institute, University of Innsbruck, Innsbruck, Austria; Department of Women's Cancer, Institute for Women's Health, University College London, London, England, UK.
Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2026 Apr 08. Date of Electronic Publication: 2026 Apr 08.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4733
DOI:10.1016/j.jval.2026.03.2235